Effects of glucose toxicity and islet purity on in vivo magnetic resonance imaging of transplanted pancreatic islets

Transplantation

Volumn 85, Issue 8, 2008, Pages 1091-1098

  Evgenov, Natalia V ^a   Pratt, John ^a   Pantazopoulos, Pamela ^a   Moore, Anna ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Glucose toxicity; Islet purity; Magnetic resonance imaging; Transplantation

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; GLUCOSE; HUMANS; IRON; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICE; OXIDES;

EID: 42549162407     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31816b183e     Document Type: Article

References (53)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Markmann JF, Deng S, Huang X, et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741.
3. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
4. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037.
5. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
6. Linetsky E, Bottino R, Lehmann R, et al. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46: 1120.
7. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8: 285.
8. Davalli AM, Ogawa Y, Ricordi C, et al. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995; 59: 817.
9. Davalli AM, Scaglia L, Zangen DH, et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161.
10. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51: 66.
11. Evgenov NV, Medarova Z, Dai G, et al. In vivo imaging of islet transplantation. Nat Med 2006; 12: 144.
12. Medarova Z, Evgenov NV, Dai G, et al. In vivo multimodal imaging of transplanted pancreatic islets. Nat Protoc 2006; 1: 429.
13. Evgenov NV, Medarova Z, Pratt J, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006; 55: 2419.
14. Tai JH, Foster P, Rosales A, et al. Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 2006; 55: 2931.
15. Eich T, Lundgren T. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography. N Engl J Med 2007; 356: 2754.
16. Kaneto H, Kajimoto Y, Miyagawa J, et al. Beneficial effects of antioxidants in diabetes: Possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 1999; 48: 2398.
17. Eizirik DL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 1992; 90: 1263.
18. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53(suppl 3): S16.
19. Leibowitz G, Yuli M, Donath MY,et al. Beta-cell glucotoxicity in the psammomys obesus model of type 2 diabetes. Diabetes 2001; 50(suppl 1): S113.
20. Maedler K, Sergeev P, Ris F, et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851.
21. Laybutt DR, Hawkins YC, Lock J, et al. Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats. Diabetologia 2007; 50: 2117.
22. Makhlouf L, Duvivier-Kali VF, Bonner-Weir S, et al. Importance of hyperglycemia on the primary function of allogeneic islet transplants. Transplantation 2003; 76: 657.
23. Melzi R, Battaglia M, Draghici E, et al. Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: Implication for mouse model. Transplantation 2007; 83: 167.
24. Montana E, Bonner-Weir S, Weir GC. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J Clin Invest 1993; 91: 780.
25. Jansson L, Eizirik DL, Pipeleers DG, et al. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J Clin Invest 1995; 96: 721.
26. Eizirik DL, Jansson L, Flodstrom M, et al. Mechanisms of defective glucose-induced insulin release in human pancreatic islets transplanted to diabetic nude mice. J Clin Endocrinol Metab 1997; 82: 2660.
27. Nacher V, Merino JF, Raurell M, et al. Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. Diabetes 1998; 47: 192.
28. Ricordi C, Lacy PE, Finke EH, et al. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413.
29. Street CN, Lakey JR, Shapiro AM, et al. Islet graft assessment in the Edmonton protocol: Implications for predicting long-term clinical outcome. Diabetes 2004; 53: 3107.
30. Scopsi L, Andreola S, Socci C, et al. Immunocytochemical detection and characterization of intrahepatic human pancreatic islets after combined liver-islet allotransplantation. Cell Transplant 1994; 3: 499.
31. Keymeulen B, Ling Z, Gorus FK, et al. Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: Graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 1998; 41: 452.
32. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
33. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060.
34. Warnock GL, Meloche RM, Thompson D, et al. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg 2005; 140: 735.
35. O'Connell PJ, Hawthorne WJ, Holmes-Walker DJ, et al. Clinical islet transplantation in type 1 diabetes mellitus: Results of Australia's first trial. Med J Aust 2006; 184: 221.
36. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J Leukoc Biol 2005; 77: 587.
37. Emamaullee JA, Shapiro AM. Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes 2006; 55: 1907.
38. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351.
39. Tiedge M, Lortz S, Drinkgern J, et al. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 1997; 46: 1733.
40. Ahn YB, Xu G, Marselli L, et al. Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection. Diabetologia 2007; 50: 334.
41. Bottino R, Balamurugan AN, Tse H, et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 2559.
42. Rossetti L, Giaccari A, DeFronzo RA. Glucose toxicity. Diabetes Care 1990; 13: 610.
43. Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 1992; 15: 442.
44. Grotting JC, Rosai J, Matas AJ, et al. The fate of intraportally transplanted islets in diabetic rats. A morphologic and immunohistochemical study. Am J Pathol 1978; 92: 653.
45. Franklin WA, Schulak JA, Reckard CR. The fate of transplanted pancreatic islets in the rat. Am J Pathol 1979; 94: 85.
46. Slater D, Mangnall Y, Smythe A, et al. The rejection of islets of Langerhans following intrahepatic transplantation in the rat. Acta Endocrinol Suppl (Copenh) 1976; 205: 295.
47. Hyon SH, Ceballos MC, Barbich M, et al. Effect of the embolization of completely unpurified islets on portal vein pressure and hepatic biochemistry in clinical practice. Cell Transplant 2004; 13: 61.
48. White SA, Djaballah H, Hughes DP, et al. A preliminary study of the activation of endogenous pancreatic exocrine enzymes during automated porcine islet isolation. Cell Transplant 1999; 8: 265.
49. Rose NL, Palcic MM, Shapiro AM, et al. An evaluation of the activation of endogenous pancreatic enzymes during human islet isolations. Transplant Proc 2003; 35: 2455.
50. Heuser M, Wolf B, Vollmar B, et al. Exocrine contamination of isolated islets of Langerhans deteriorates the process of revascularization after free transplantation. Transplantation 2000; 69: 756.
51. Clayton HA, Davies JE, Sutton CD, et al. A coculture model of intrahepatic islet transplantation: Activation of Kupffer cells by islets and acinar tissue. Cell Transplant 2001; 10: 101.
52. Sigrist S, Ebel N, Langlois A, et al. Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation. Transplant Proc 2005; 37: 3516.
53. Ito T. Can measurement of chemokines become useful biological and functional markers of early-stage chronic pancreatitis? J Gastroenterol 2007; 42 (suppl 17): 72.